We performed a @ - to @-month , multicenter , double-blind trial in patients with advanced Parkinson disease ( PD ) who were randomly assigned to receive bilateral AAV@-neurturin injected bilaterally into the substantia nigra ( @ @ ( @ ) vector genomes ) and putamen ( @ @ ( @ ) vector genomes ) or sham surgery .